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A simple procedure was devrscd for Isolatmg from homogenates of mltotlc cells the human homolog to the fss~on yeast c&2 gene product The 
ldentlty of the purified protem was established with antI-p34”“’ antlbodles and pl3”“‘, both specific hgands for p34c“c* Active-site labelmg with 
oxldlzed [cz”P]ATP showed the purified moIecule to be an ATP-bmdmg protein Its ablhty to phosphorylate casem but not hlstone, and Its 
phosphorylatlon on tyrosme, detected by ant;-phosphotyrosme antIbodIes, mchcates the form of p3slcdcz 
Purified quantmes of human ~34”” 
purified IS the mactlve or apocnzymc form 
should be of consldeeable value m estabhshmg the mechamsm of Its actlvatlon at nutosls by phosphatases 
Mltosls, Phosphotyrosmc, p34”“(‘, Human 
1 INTROIXJCTION 
The protein kinase encoded by the yeast c&t gent or 
its homologs m other species plays an essential role m 
triggermg mltotlc events [I ,2] In the human cell, ~34’~” 
has been detected m a number of dlstmct forms at mlto- 
SIS, both on the basis of size [3,4] or lsoelectrlc point 
[5,6]. Only a high molecular weight form [3,4], thought 
to contam both cychn B [6,71 and ~65, a protem phos- 
phatase present as a dlsulfide-linked dlmer at mltosls 
[8,9], possesses the HI kmase activity characteristic of 
M phase-promoting factor (MPF), other forms have 
only casem kmase activity. Although the several lso- 
forms of human ~34 dlstlngulshable by lsoelectrlc focus- 
mg [5,6] likely derive from dlfferentlal phosphorylatlon 
at multiple sites [lo], the precise relatlonshlp of these 
several forms with the active, PI1 lcmase complex or 
holoenzyme 1s unclear 
Activatron of the latent I-I1 kmase activity of ~34’~” 
is known to occur m several steps. Phosphorylatlon of 
p34’=Q during interphase may be required for assembly 
of the high molecular weight holoenzyme [3], while sub- 
sequent dephosphorylatlon of ~34”“‘~ (partrcularly on 
tyrosine) IS necessary for actlvatlon of hlstone I-I1 ki- 
nase activity [1,2]. These conclusions derive prmclpaIly 
from exammation of the phosphorylatlon state of 
p34’d’J lmmunopreclpltated from crude extracts or from 
gel-filtration column fractions There is evldencc, how- 
ever, that at least tn mammalian cells ~34‘~‘~ may be 
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partially dephosphorylated during lmmunopreaplta- 
tlon [11] Avallablhty of a purified ~34”~“~ apoenzyme 
would circumvent this problem by allowmg dnect de- 
termination of ~34’~‘~ kmase activity as a function of 
controlled alterations m its phosphorylation state This 
report describes a rapld purification of ~34’~” apoen- 
zyme from human mltotlc cell extracts 
2. MATERIALS AND METHODS 
2 1 Cell erlracts 
Human D9g/AH-2 cells were cultured as previously described [X] 
Mltotic cells (mltotlc Index R-97%) were collected by mechamcal 
shake-off followmg 16-20 h mcubatlon m 50 @ml nocodazole Cell 
homogenates were prepared as described [S], except that NaF and 
2-glycerophosphate were Increased to 50 mM and 10 mM, respec- 
tlvely 
2 2 PurrJcarrort 0j-p3#~~‘~ apocnzyme 
MItotlc extracts were frdctlonated by (NH&SO, prcclpltatlon ds 
prcvlously dcscrlbed [8] The 20-60% frdctlon (approximately IO mg 
of protein) was taken up m 2 ml of 10 mM Trls-HCI, 50 mM NaCI, 
1 mM EDTA (pH 7 4,20°C). transferred to6,4-mm diameter, 12 OOO- 
14 000 molecular weight cut-off SpectWPor membrane tubing (Spcc- 
trum Medical Industries) and dialyzed for 18 h dgamst 2 I of the same 
buffer contdmmg 0 1 mM DTT, 5 mM NdF, IO mM t-glycerophos- 
phate, 0 1 mM phcnylmcthylsulfonyl f uoride, 10 pg/ml Icupeptm. 0 1 
mM benzamldmc, 1 &ml aprotmm, 1 pg/rnl pepstatm A, 0 I mM 
ZnCI,, and 1 mM ATP (dlalysls buffer) D~dlysts was carrlcd out dt 
4°C nt which temperature the pH of the buffer rose to 8 0, concom- 
Itant with the appcarancc of J preclpitatc in the dldlysls tubmg The 
preclpitdtc wds colltctcd by centrifugatlon al 4”C, washed once with 
ILc-cold didlysls buffer and extracted on ICE III 2 mlof20 mM Bis-Trls, 
SO mM NaCI, 4 mM MgCII, 0 1 mM DTT (pH 6 9) contammg 10 mM 
2-glyccrophosphatc, 5 mM NaF, 0 I mM phcnylmcthylsulfonyl f uo- 
ride, 10 jrg/ml Icupcptm, 0 1 mM ZnCl, and 1 mM ATP (extraction 
buffer) The rcm,unmg preclpltdtc was removed byccntnfugdtlon dnd 
drscardcd ‘I hc sqcrndtant was apphcd to a DEAC-Scpharosc CL GB 
column. atld the non-bmdmg fraction wds collected. conccntrntcd 
using .I Ccntricon 10 canccntrator (Amicon), and slorcd dt 4°C until 
192 
Volume 291, numbee 2 FEBS LETTERS October 1991 
use The SIZC of the purtfied apoenzyme was determmed by gel-filtra- 
tton chromatography m :c iaM sod&urn phosphate, 500 mM NaCt (pH 
6 9) on Sepharose CL-6B, usmg a 50x I cm column. 
2 3 Gel elecr~opliorests and unmur~oblottmng 
Gel electrophorests and lmmunoblottmg weee performed as prevt- 
ously described [8] Blots were peobcd overmght at 4°C wtth 54 oe JP4 
ascttes, an anttbody agatnst the PSTAIR regtor of ~34”“~ [i2], antt- 
phosphotyrosme anttbodtes [13], antt-p65 anttbodtes [g] or antt- 
human cychn Et Antrbodres [7] Sxtver stammg was according to [14] 
2 4 Protern krnase assay 
Protem kmase assays were carrted out as prevtously descetbed [8], 
except that some reacttons contamed 1 mg/mt of dephosphorylated, 
pa&ally hydrolyzed casem ]15] rather than 1 mg/ml of htstone WI as 
substrate Reacttons were mtttated by the addmon ofenzyme and were 
tennmated after 10 mm at 37°C by addmg 3x etcctrophoresls ample 
buffer for analysts by SDS-PAGE and autoradtography 
2 5 ,913~Sepkarose brndmg 
Bmdmg of samples to Sepharosc CL-4B to whtch p13 had been 
coupled was carned out essenttally accordmg to [16], except that the 
samples wete apptted m dtalysts buffer OP extractlon buffer Fotlowmg 
bmdmg, beads weee washed exhausttvcly wtth 50 mM trtethanola- 
mme, 0 9% NaCt, 0 1% SDS, 0 5% Tween 20,2 mM EDTA (pH 7 4) 
3 RESULTS 
3 1 Isolatron of a 34-kDa casein kinme 
When Isolating protein kmases from mitotrc cell ex- 
tracts, substantral loss of casem kmase actrvrty was 
noted durmg dralysrs of (NHJ2SQ4 fractions To drs- 
cover the source of the loss, the translucent precipitate 
formed when 20-60% (NH&SO, fractrons of mrtotrc 
cell extracts were dialyzed at pH 8 0 at low ronlc 
strength was extracted at pH 7 0, and the resolubrhzed 
portion analyzed by SDS-PAGE and sliver stammg, a 
34-kDa polypeptrde (Fig. lA, lane 1) was prominent 
DEAE chromatography of the resolublhzed fraction 
produced an cssentrally homogeneous preparation (lane 
CO8 his 




PST&la $65 CYCB 
FIN 2 Western blot of the 34-kDa polypepttde and hotoenzyme frac- 
tion Lanes t-3, p34 apoenzyme, lane 4, MPF-contammg (NH.,I,)$X?~ 
fraction remammg soluble fotlowmg dtatysts at pH 8 0 Anttbodtes 
used dre mdtcatcd bcto:. czch blot s!r~p 
2) which eluted from a gel-filtration column as a smgle 
peak of molecular weight 30-40 kDa (data not shown). 
Active-ate labelmg with penodate-oxidized [cx-~~PJATP 
[17] revealed the 34kDa polypeptrde to be the only 
ATP-hmdmg protein present (Fig. ll3, lanes 3 and 4). 
The preparation readily phosphorylated casem, but did 
not phosphorylate histone to any appreciable extent 
(Fig. lG, lanes 5 and 6), consrstent with the substrate 
speclficrty reported for the uncomplexed apoenzyme 






Fig 1 Isoldtton of d 34.kDa c&em kmase A Stlvcr stam of prcclpt- 
tdtc (tanc I) and DEAL-put&d protcm (Idnc 2) Approunnatcly 100 
ng of protcm wcrc toddcd per tanc B Acttvc-snc labctmg of DEAL- 
punficd protcm m the .tb<enrc (tanc 3) or prcscncc (lane 4) of I mM 
unl&led ATP C C&em (I.mc 5) and h~stonc (Idnc 6) km~sc acuvny 
of DEAF-purtficd protein 
PSTAIW P- tyr P= 
FIN 3 Western blot of protcm bound by pt3-Scphdrose ape, ~34’~” 
apoenr.yme prepdrdtlon, M MPF-contammg (NH&SO., fracuon rc- 
mauung soluble at pH 8 0 I?, pi 3.Scphdrose-bound protem, N, PI 3- 
Scph,~rose non-bmdmg protcm Antlbodtes used XC Indicated blow 
CdCt! blot seetton 
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3 2. Mfmficat~o~ as ~34’~” apoenzyme 
The isolated 34-kDa polypeptide was tested for reac- 
tivtty wtth hgands specific for ~34’~“. As shown m Ftg 
2, lane 1, the 34-kDa polypeptlde was recognized on 
Western blots by anttbodies agamst the hlghly-con- 
served PSTAIW sequence of 1p34’~” [12], two mono- 
clonal antibodies raised against fission yeast ~34’~” 
(JP4 and 94, [5]) also recognized the molecule (data not 
shown). When the preparation was probed with anti- 
p65 or anti-eyclin B antrbodles, no reactivity was 
detected (lanes 2 and 3), demonstrating the absence of 
the holoenzyme from the preparation. Eane 4 de- 
monstrates the presence of cyclm B m the fraction 
remaining soluble after prectpltatron of the apocnzyme, 
this fraction also contains ~65 (see below) 
The product of the yeast sucl gene, ~13, is able to 
clear p34”“2 from mitottc extracts when unmoblllzed on 
Sepharose beads [1,2]. As shown m Fig. 3 (panel A, 
apa), mcubation of the purified p34”“* apoenzyme with 
pl3-coated Sepharose completely removed antl-p34’d’2 
imrnunoreactive material. As would be predicted from 
its lack ofhrstone kmase activity, the pl3-bound ~34”~‘~ 
was phosphorylated on tyrosme as Judged by an anti- 
phosphotyrosine antibody (Panel l3, apo). In agreement 
with results obtained m Xenopus, phosphotyrosine was 
found on each component of the ~34~“~ triplet [I 81 pl3- 
Sepharose also quantitattvely removed 834’““” which 
remained soluble after the apoenzyme had precipitated 
from the (Nl-L&X& fraction during dialysis (Panel A, 
M). In contrast, however, this pl3-bound ~34’~” con- 
tamed very little phosphotyrosme (Panel B, M) Con- 
sistent with this latter form being part of the active 
P34”“* holoenzyme (MPF), pl3-Sepharose removed 
~65 along with ~34”” (Panel C). Gamma counting of 
bands excised from blots showed that approximately 
two-thirds of the p34”/‘” present m the 20-60% 
(NEI&SQ fraction was complexed in MPF and appro- 
ximately one-thud was apoenzyme 
4. DISCUSSION 
This report describes a simple procedure for lsolatmg 
the apoenzyme form of the ~34’~” kmase from human 
mitotic cells Identity of the purified molecule with 
p34rdc2, suggested by its protein kinase activity and mo- 
lecular weight, was confirmed by labeling with specific 
anti-p34cd’2 antibodies and by adsorption on pl3- 
Sepharose While p3Y”’ is predicted from its kmdse 
actwlty and from its nucleotlde sequence to bind ATP, 
this IS the first direct demonstration that p34”” is an 
ATP-bmdmg protein The absence of other components 
of MPF from the purified preparation identifies the 
form isolated as the apoenzyme That the purified 
p34’“2 IS phosphorylated on tyrosme and lacks Hl 
kmase activity further drstmguishes it from the ho- 
loenzyme and identifies it as inactive apoenzyme The 
ability to separate the human ~34’~” apoenzyme and 
holoenzyme species, along with the demonstration that 
the human MPF holoenzyme contains virtually no 
phosphotyrosme, rectifies earlier observations to 
coincide with those made m other species [3,5]. Avail- 
ability of homogemeous p3@” apoenzyme will be useful 
in searching for the physiological activators of the HI 
kmase activity of ~34’~” and m evaluating its potential 
substrates. 
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